Dolutegravir: successful experience in a challenging patient

AIDS. 2015 Jun 19;29(10):1269-71. doi: 10.1097/QAD.0000000000000696.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / methods
  • Drug Resistance, Viral*
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • HIV Integrase / genetics
  • HIV Protease / genetics
  • HIV Reverse Transcriptase / genetics
  • HIV-1 / drug effects*
  • HIV-1 / genetics*
  • HIV-1 / isolation & purification
  • Heterocyclic Compounds, 3-Ring / therapeutic use*
  • Humans
  • Male
  • Mutation, Missense
  • Oxazines
  • Piperazines
  • Pyridones
  • Treatment Outcome
  • Viral Load

Substances

  • Anti-HIV Agents
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir
  • HIV Integrase
  • reverse transcriptase, Human immunodeficiency virus 1
  • HIV Reverse Transcriptase
  • HIV Protease
  • p16 protease, Human immunodeficiency virus 1
  • p31 integrase protein, Human immunodeficiency virus 1